Acovog M 0.3 Tablet ER
Marketer
Acmedix Pharma LLP
Salt Composition
Metformin (500mg) + Voglibose (0.3mg)
Overview Acovog M 0.3 Tablet ER
Diabetace M 0.3 Extended-Release Tablet is an antidiabetic medication, a combination therapy for adult type 2 diabetes. It manages blood glucose levels. This medication should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Possible side effects include nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin reactions. These are typically transient and self-limiting, but consult your physician if persistent or concerning. They can offer management strategies. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Prior heart conditions should be disclosed to your doctor before starting treatment. Pregnant or lactating individuals should seek medical counsel before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended by your doctor.
Uses of Acovog M 0.3 Tablet ER
Managing type 2 diabetes
Major Benefits of Acovog M 0.3 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. It is recommended to take Acovog M 0.3 Tablet ER with a meal.
Common Side effects of Acovog M 0.3 Tablet ER:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Acovog M 0.3 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Acovog M 0.3 Tablet ER should be administered with a meal.
How Acovog M 0.3 Tablet ER works:
Extended-release Acovog M 0.3mg tablets contain a dual antidiabetic medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Acovog M 0.3 Tablet ER is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Acovog M 0.3 mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Acovog M 0.3 mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is generally unaffected by Acovog M 0.3 Tablet ER. Nevertheless, patients using this medication concurrently with other antidiabetic drugs, including sulfonylureas, insulin, and repaglinide, should be aware of the potential for low blood sugar.
KidneyCAUTION
Patients with impaired kidney function should use Acovog M 0.3 Tablet ER cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Kidney function should be regularly monitored during treatment; physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the use of Acovog M 0.3 Tablet ER in individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Acovog M 0.3 Tablet ER :
Should you forget to take a dose of your Acovog M 0.3 Extended-Release tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Acovog M 0.3 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |



